Granted Patent
B2
US 9,675,654 · App. 14/260,876 · Granted Jun 13, 2017
Phytocannabinoids in the treatment of cancer
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.
Claims (1)
1. A pharmaceutical product consisting essentially of (1) isolated CBD and temazolamide, (2) isolated THC and temazolamide, or (3) a combination of isolated CBD, isolated THC and temazolamide, wherein the pharmaceutical product is packaged for administration separately, simultaneously or sequentially.
Assignments (4)
CHANGE OF NAME
Recorded May 13, 2025
From: GW PHARMA LIMITED
To: JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED
Reel/Frame 071103/0949 →
SECURITY AGREEMENT
Recorded Jul 22, 2021
From: GW PHARMA LIMITED; GW RESEARCH LIMITED
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056958/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 21, 2017
From: OTSUKA PHARMACEUTICAL CO., LIMITED
To: GW PHARMA LIMITED
Reel/Frame 043346/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 8, 2014
From: PAROLARO, DANIELA; MASSI, PAOLA; IZZO, ANGELO ANTONIO; BORRELLI, FRANCESCA; AVIELLO, GABRIELLA; DI MARZO, VINCENZO; DE PETROCELLIS, LUCIANO; MORIELLO, ANIELLO SCHIANO; LIGRESTI, ALESSIA; ROSS, RUTH ALEXANDRA; FORD, LESLEY ANN; ANAVI-GOFFER, SHARON; GUZMAN, MANUEL; VELASCO, GUILLERMO; LORENTE, MAR; TORRES, SOFIA; KIKUCHI, TETSURO; GUY, GEOFFREY; STOTT, COLIN; WRIGHT, STEPHEN; SUTTON, ALAN; POTTER, DAVID; DE MEIJER, ETIENNE
To: GW PHARMA LIMITED; OTSUKA PHARMACEUTICAL CO. LIMITED
Reel/Frame 032849/0112 →